Endpoints News 2026-02-18 Lilly's Zepbound, Taltz combo data in psoriasis and weight loss; Novartis bolsters Rhapsido results
Roche Media 2026-02-18 Paragon's latest biotech will try to slow Alzheimer's like Roche - Endpoints News
Endpoints News 2026-02-17 FDA rejects Disc Medicine's rare disease drug despite granting it a commissioner voucher
Endpoints News 2026-02-14 Moderna vs FDA; Paul Hudson out at Sanofi; Why clinical trials are so costly; and more
Endpoints News 2026-02-13 Lilly appeals retatrutide classification ruling in case that could impact compounders